Nintedanib (Ofev)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Nintedanib (Ofev), covering 2024-08-22 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON) [Phase 3]